BUSPIRONE ANALOGS AS LIGANDS OF THE 5-HT1A RECEPTOR .1. THE MOLECULAR-STRUCTURE OF BUSPIRONE AND ITS 2 ANALOGS

被引:45
作者
CHILMONCZYK, Z
LES, A
WOZNIAKOWSKA, A
CYBULSKI, J
KOZIOL, AE
GDANIEC, M
机构
[1] UNIV WARSAW,DEPT CHEM,PL-02093 WARSAW,POLAND
[2] MARIE CURIE SKLODOWSKA UNIV,DEPT CHEM,PL-20031 LUBLIN,POLAND
[3] ADAM MICKIEWICZ UNIV POZNAN,DEPT CHEM,PL-60780 POZNAN,POLAND
关键词
D O I
10.1021/jm00010a015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An interdisciplinary (X-ray, H-1 and C-13 NMR, IR, and theoretical quantum mechanical) study on the potent 5-HT1A receptor ligand buspirone (1) and its two structural analogues, mesmar (4,4-dimethyl-1-[4-[4-(2-quinolinyl)-1-piperazinyl]butyl]-2,6-piperidinedione) (2) and kaspar (8-[4-[4-(2-quinolinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione) (3), has been reported. The results have shown that buspirone-like molecules should appear in an extended rod-shape form, possessing several potential interaction sites with the receptor.
引用
收藏
页码:1701 / 1710
页数:10
相关论文
共 44 条
[21]  
HUMBLET C, 1980, ANNU REP MED CHEM, V15, P267
[22]  
KALINOWSKIHO, 1984, 13C NMR SPEKTROSKOPI, P106
[23]  
MAJ J, 1980, POL J PHARMACOL PHAR, V32, P495
[24]  
MAZUREK AP, 1984, INT J QUANTUM CHEM Q, V11, P183
[25]   A 3-D MODEL FOR 5-HT1A-RECEPTOR AGONISTS BASED ON STEREOSELECTIVE METHYL-SUBSTITUTED AND CONFORMATIONALLY RESTRICTED ANALOGS OF 8-HYDROXY-2-(DIPROPYLAMINO)TETRALIN [J].
MELLIN, C ;
VALLGARDA, J ;
NELSON, DL ;
BJORK, L ;
YU, H ;
ANDEN, NE ;
CSOREGH, I ;
ARVIDSSON, LE ;
HACKSELL, U .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) :497-510
[26]   STRUCTURE ACTIVITY RELATIONSHIP STUDIES OF CENTRAL-NERVOUS-SYSTEM AGENTS .5. EFFECT OF THE HYDROCARBON CHAIN ON THE AFFINITY OF 4-SUBSTITUTED 1-(3-CHLOROPHENYL)PIPERAZINES FOR 5-HT1A RECEPTOR-SITE [J].
MOKROSZ, JL ;
PIETRASIEWICZ, M ;
DUSZYNSKA, B ;
CEGLA, MT .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (13) :2369-2374
[27]   ETHOPHARMACOLOGICAL STUDIES DIFFERENTIATE THE EFFECTS OF VARIOUS SEROTONERGIC COMPOUNDS ON AGGRESSION IN RATS [J].
MOS, J ;
OLIVIER, B ;
TULP, TM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (04) :1384-1384
[28]  
MURPHY DL, 1991, PHARMACOL REV, V43, P527
[29]  
NARAYSZABO G, 1989, TRENDS MED CHEM 88, P29
[30]  
RICHARDS WG, 1993, QUANTUM PHARM, P189